Home > Blog > European medicines and medical devices future trends article

1 min read

European Medicines and Medical Devices: Future Trends

Success Stories Project Management Regulatory Consulting Strategic Consulting Regulatory Submissions Marketing Applications

Based on an online seminar presentation made in collaboration with TOPRA and Veristat, this article dives into the future of the European medicines and medical devices industry and the changes in legislation that are being prompted by the evolving pharmaceutical environment. Regulatory blog March 23

On 25 November 2020, the European Commission (EC) adopted the patient-centric New Pharmaceutical Strategy for Europe and published its roadmap for the revision of the general pharmaceutical legislation in 2021. The European Commission has begun initiating work in several areas, including the pediatric and orphan review.

In this article, you will get a comprehensive overview of the following:  

  • Unmet medical needs and how the New Pharmaceutical Strategy aims to prioritize them.
  • Changes in the Orphan and Pediatric legislation review.
  • The European Commission’s plans for ensuring the accessibility and affordability of medicines in all member states.
  • Future objectives for innovation and digital transformation in the European pharmaceutical industry.
  • New pharmaceutical strategy for Europe looking forward.

Read the full article to learn more: https://www.regulatoryrapporteur.org/european-medicines-and-medical-devices-future-trends/222.article

 

2 min read

Operationalizing Adaptive Design for FDA's One-Trial Era

Sep 22, 2026  Veristat Events

Operationalizing Adaptive Design for FDA's One-Trial Era

October 20, 2026 : 11:00 AM ET

On February 18, 2026, the FDA...

2 min read

Meet Veristat at the iC³ Life Science and Healthcare Innovation Summit

Aug 26, 2026  Veristat Events

Where Life Science Innovation Moves Forward

iC³ Life Science and Healthcare Innovation Summit:

September 24-25, 2026 -...